![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Isin Baral Kulaksizoglu
Publisher: Adis International
ISSN: 1172-7047
Source: CNS Drugs, Vol.21, Iss.6, 2007-01, pp. : 473-481
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Ciclosporin is effective in the treatment of patients with severe myasthenia gravis
Inpharma, Vol. 1, Iss. 1489, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Role of Estrogen in the Aetiology and Treatment of Mood Disorders
CNS Drugs, Vol. 15, Iss. 10, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Riluzole in the Treatment of Mood and Anxiety Disorders
By Pittenger Christopher Coric Vladimir Banasr Mounira
CNS Drugs, Vol. 22, Iss. 9, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Immunomodulatory treatment for myasthenia gravis
Inpharma, Vol. 1, Iss. 1283, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Diagnosis and Management of Autoimmune Myasthenia Gravis
Clinical Drug Investigation, Vol. 31, Iss. 1, 2011-01 ,pp. :